Apneic spells and transcutaneous PO2: treatment with caffeine, 19-year follow-up.
D001049:Apnea / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D001784:Blood Gas Analysis; D001794:Blood Pressure; D002110:Caffeine / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006339:Heart Rate; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy / Q000503:physiopathology*; D007234:Infant, Premature; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D012867:Skin / Q000098:blood supply
D002110:Caffeine; D010100:Oxygen